Table 3.
Correlation between hematological parameters and cutaneous vasculitis lesions.
| Cutaneous Vasculitis Lesions | ||
|---|---|---|
| Correlation Coefficient (r) | p-Value | |
| Lymphocytes (109/µL) | −0.432 | 0.001 * |
| Neutrophils (109/µL) | 0.389 | 0.001 * |
| Monocytes (109/L) | −0.150 | 0.097 |
| Platelets (109/L) | 0.467 | 0.001 * |
| NLR | 0.481 | 0.001 * |
| PLR | 0.524 | 0.001 * |
| MLR | 0.375 | 0.001 * |
| MPWPCTR | −0.080 | 0.380 |
| PDWPCTR | −0.029 | 0.753 |
| C3 (mg/dL) | −0.101 | 0.267 |
| C4 (mg/dL) | −0.123 | 0.174 |
| IgA (mg/dL) | −0.067 | 0.457 |
| IgG (mg/dL) | −0.168 | 0.063 |
| IgM (mg/dL) | 0.057 | 0.531 |
| Gammaglobulins g/dL) | 0.674 | 0.001 * |
| RF (U/mL) | 0.176 | 0.051 |
| hs-CRP (mg/L) | 0.077 | 0.398 |
| Anti-Ro/SSA (U/mL) | 0.211 | 0.280 |
| Anti-La/SSB (U/mL) | 0.414 | 0.791 |
| VAS pain score (mm) | 0.571 | 0.001 * |
| ESSDAI score | 0.444 | 0.001 * |
Abbreviation: MPVPCTR, mean platelet volume to Plateletcrit ratio; PDWPCTR, platelet distribution width to platelet crit ratio; MLR, monocyte to lymphocyte ratio; NLR, neutrophil to lymphocyte ratio; PLR, platelet to lymphocyte ratio; RF, rheumatoid factor; C3 and C4, complement 3 and 4; hs-CRP, high sensitivity C-reactive protein; ANA, antinuclear antibodies; SD, standard deviation; VAS, visual analogue scale; ESSDAI, EULAR Sjögren’s Syndrome Disease Activity Index. Bold values indicate statistical significance (* p < 0.05). Data were analyzed using the Spearman approach.